Drugmaker GSK PLC won’t have to answer a securities fraud class action stemming from its concealment of a link between Zantac and a cancer-causing substance because it was filed too late.
The French pharmaceutical company Sanofi says it has reached an agreement to resolve 4,000 cases in the U.S., in which plaintiffs are linking the discontinued heartburn drug Zantac — and its active ...
CVS Pharmacy announced Saturday that it has suspended the sale of all Zantac brand and CVS Health-brand ranitidine products until further notice The announcement comes in response to an alert from the ...
Top Class Actions: Katharine Van Tassel, visiting professor of law, discussed the potential for lawsuits following the recall of the heartburn medication Zantac.
WASHINGTON — The U.S. Food and Drug Administration has approved a reformulated version of ranitidine, which was sold widely under the brand name Zantac, allowing the acid-reducing drug to return to ...
Judge Adalberto Jose Jordan of the U.S. Court of Appeals for the Eleventh Circuit/photo by J. Albert Diaz/ALM The U.S. Court of Appeals for the Eleventh Circuit appeared ready to pick apart U.S.
Drugmaker Sanofi announced on Friday a voluntary recall of the heartburn drug Zantac from all stores in the United States and Canada amid investigations into the presence of a carcinogen discovered in ...
British pharmaceutical group GSK reported Wednesday a sharp rise in annual net profit, boosted by strong sales of HIV, respiratory and cancer treatments as it recovered from costly US lawsuits over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results